Hints and tips:
Related Special Reports
...Adrian van den Hoven, director-general of generic drugmakers association Medicines for Europe, said the body “strongly supports” the move to improve Europe’s medicine supply security in the post-pandemic...
...The British Generic Manufacturers Association said on Monday that the voluntary scheme for branded medicines pricing and access (Vpas) would dent competition in the market for off-patent medicines delivered...
...EU manufacturing is heavily reliant on imported active pharmaceutical ingredients from China and India....
...The writer is chief executive of the British Generic Manufacturers Association (BGMA) The UK is now in a global competition for medicines....
...Disruption to inspections increases the risk of Chinese production sites losing their certification for western markets, exacerbating an already strained supply chain for generic pharmaceuticals....
...Some drugmakers have warned that prices for off-patent, generic medicines are now so low it has become unattractive to continue making them. Generics make up the majority of drugs used globally....
...In the UK, 99 generic drugs were short in January, double the number counted two years ago, according to the British Generic Manufacturers Association, a trade body....
...According to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based lobby group, the US attracted a third more R&D investment than Europe in 2010....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...The standard treatment is oxytocin, and many lives could be saved by improving generic supplies of this medicine — whether from multinational companies or, even better, by making more drugs locally in factories...
...In 2021, about 30,000 monkeys were bred in China, according to China’s NHP Breeding and Development Association, about a third less than required....
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
...The European Federation of Pharmaceutical Industries and Associations, a Brussels-based industry group, said the removal of the exemption would make it more difficult for drug companies to provide medicines...
...and Associations, a global industry group....
...The results focus on the remaining business, focused on innovative drugs, after Novartis spun out its generics division Sandoz this month....
...This week I spoke to Mark Samuels, the boss of the British Generic Manufacturers Association, which represents the UK end of an industry that provides four out of five drugs prescribed by the NHS....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...The Swiss group is a cleaner proposition after spinning off its generics business Sandoz in October. But there is no time to stand still. Narasimhan must show that Novartis can increase revenues....
...That ambition, the Association of the British Pharmaceutical Industry says, is contingent on “[making] sure we do not forget the lessons we learned during the pandemic”....
...While the company does give away generic insulin in developing markets, the foundation can focus on running programmes using cheap generic drugs — those that are available now, such as statins to lower cholesterol...
...The industry is concerned by a cut in the number of years of market exclusivity — the period before a drugmaker faces competition from generic manufacturers — from 10 to eight years....
...Instead, Isomorphic chose to sign deals with just two pharmaceutical companies....
...The Swiss pharmaceuticals group is following many rivals to focus its operations on higher-value innovative treatments rather than the cheaper off-patent drugs made by Sandoz, including generic versions...
...Lykos Therapeutics, a corporate offshoot of the non-profit Multidisciplinary Association for Psychedelic Studies, is also awaiting a decision from the FDA on its MDMA-assisted therapy for post-traumatic...
International Edition